Jian-Ming Xu
Overview
Explore the profile of Jian-Ming Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
153
Citations
1883
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Qin S, Ji J, Xu R, Wang W, Tang Y, Bi F, et al.
Oncologist
. 2021 May;
26(9):e1567-e1580.
PMID: 34003545
Background: Real-world safety and effectiveness data for trastuzumab plus chemotherapy treatment of patients with HER2-positive metastatic gastric cancer (mGC) in China are lacking. Patients And Methods: EVIDENCE was a prospective,...
12.
Zeng X, Sheng X, Wang P, Xin H, Guo Y, Lin Y, et al.
Hepatol Int
. 2021 Jan;
15(1):155-165.
PMID: 33385299
Background And Aims: Rifaximin has been recommended as a prophylactic drug for hepatic encephalopathy (HE) and spontaneous bacterial peritonitis (SBP). This study aims to explore whether low-dose rifaximin can prevent...
13.
Jia R, Zhao C, Li P, Liu R, Zhang Y, Chen H, et al.
Oncol Lett
. 2020 Dec;
21(1):68.
PMID: 33365079
Esophageal squamous cell carcinoma (ESCC) is a highly malignant and deadly tumor. Radiation therapy is one of the primary treatments for locally advanced ESCC. However, the biomarkers for prognosis of...
14.
Li Y, Qiu X, Chen J, Zhang Y, Li J, Xu J, et al.
World J Gastrointest Oncol
. 2020 Dec;
12(12):1416-1427.
PMID: 33362912
Background: For the rarity of type 3 gastric neuroendocrine tumours (g-NETs), their clinicopathological characteristics and prognosis are not well illustrated. Aim: To describe the clinicopathological features and outcome of type...
15.
Wang F, Liu T, Yuan X, Luo H, Gu K, Yuan Y, et al.
Am J Cancer Res
. 2020 Oct;
10(9):3037-3046.
PMID: 33042632
Gastric cancer (GC) is the second most common cancer in China. The ToGA study showed that trastuzumab in combination with fluoropyrimidine plus cisplatin prolonged overall survival (OS) in patients with...
16.
Zhao Y, Xue D, Wang Y, Zhang R, Sun B, Cai Y, et al.
Endoscopy
. 2018 Nov;
51(4):333-341.
PMID: 30469155
Background: We developed a computer-assisted diagnosis model to evaluate the feasibility of automated classification of intrapapillary capillary loops (IPCLs) to improve the detection of esophageal squamous cell carcinoma (ESCC). Methods:...
17.
Zhou J, Sun H, Wang Z, Cong W, Wang J, Zeng M, et al.
Liver Cancer
. 2018 Oct;
7(3):235-260.
PMID: 30319983
Background: Hepatocellular carcinoma (HCC) (about 85-90% of primary liver cancer) is particularly prevalent in China because of the high prevalence of chronic hepatitis B infection. HCC is the fourth most...
18.
Wang Y, Hong R, Xie Y, Xu J
Curr Med Sci
. 2018 Aug;
38(2):236-244.
PMID: 30074181
Melatonin has been reported to inhibit hepatic fibrosis and the mechanism may be correlated to its anti-oxidant effect. Nevertheless, the mechanism is not completely identified. This study was conducted to...
19.
Raymond E, Kulke M, Qin S, Yu X, Schenker M, Cubillo A, et al.
Neuroendocrinology
. 2018 Jul;
107(3):237-245.
PMID: 29991024
Background: In a phase III study, sunitinib led to a significant increase in progression-free survival (PFS) versus placebo in patients with pancreatic neuroendocrine tumours (panNETs). This study was a post-marketing...
20.
Tang M, Xu J, Song S, Mei Q, Zhang L
Medicine (Baltimore)
. 2018 Feb;
97(7):e9755.
PMID: 29443736
Acute pancreatitis in pregnancy (APIP) poses a serious threat to the mother and her fetus, and might lead to fetal loss including miscarriage and stillbirth in certain patients. We sought...